致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag
目录号 NBL-241992
别名 TRAIL R1/DR4/TNFRSF10A; DR4; CD261; TNFRSF10A; TRAIL-R; APO2; TRAIL R1; MGC9365
外观 see COA
分子量 Pro34-Asn239
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 O00220
备注2
目录号 规格 价格 库存状态  
NBL-241992-100ug 100ug Inquire Inquire
NBL-241992-1mg 1mg Inquire Inquire
NBL-241992-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag


Catalog#:

NBL-241992


Description:

NebuSelect™ Recombinant Human TRAIL R1/DR4/TNFRSF10A, hFc-tag(Cat#NBL-241992) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Pro34-Asn239.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.


Target Name:

TRAIL R1/DR4/TNFRSF10A; DR4; CD261; TNFRSF10A; TRAIL-R; APO2; TRAIL R1; MGC9365


Target Information:

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces apoptosis selectively via its interaction with the death receptors TRAILR1/DR4 and TRAILR2/DR5 in a wide range of cancers, while sparing normal cells. Despite its tremendous potential for cancer therapeutics, the translation of TRAIL into the clinic has been confounded by TRAIL-resistant cancer populations.


Amino Acid Sequence: 

Pro34-Asn239


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品